Get started
AMGEN INC CEDEAR EACH 10 REP 1AA

AMGEN INC CEDEAR EACH 10 REP 1

No trades
USDD
USD
No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Seasonals Bonds

AMGDB trade ideas

AMGN Attractive 237$ levelAMGN is at an attractive buying zone at 237$ per share. I see stock going up 5-10% where I would start taking profits. Using leverage or options would be a good play for this stock. Technical Info: Stock is at a confluence of several moving averages which will help rebound. The stock is trading in sideways/up pattern and therefore is likely to continue or go up. RSI is neither overbought or oversold. Once RSI gets above 50, high probability of stock going up 5%-10%.
NLong
by TickTackTrades
$AMGN - NR Picks Nov 22Amgen se dedica a descubrir, desarrollar, fabricar y ofrecer terapias humanas en todo el mundo. Se centra en las áreas de inflamación, oncología / hematología, salud ósea, enfermedades cardiovasculares, nefrología y neurociencia. La compañía tuvo una reacción positiva a inicios de mes cuando presentó una actualización de su farmaco para la psoriasis, durante el mes el precio de la accion fue cayendo hasta estar cerca a los niveles pre-reacción. Este retroceso se ve como una oportunidad para Amgen, recordemos que esta compañía es una de las mas importantes del sector. Creemos que el interes de los inversiores durante el mes ha cambiado a compañías que estan brindando actualizaciones sobre el desarrollo de la vacuna contra el COVID-19.
NLong
by NewroadTrader
Understanding range highs and lows are all you need. #stocksBack on October 27th I made a post highlighting a potential reversal as we approached the range lows from back in June. Over the future months the stock tested the lows, found support, and is not heading toward highs. Range highs and lows and major support and resistance areas have value because they indicate where there is likely to be heavy order flow. In this case it AMGN reacted well and held the lows creating a great risk/reward opportunity.
N
by IngenuityTrading
2
Seems like a strong breakout for $AMGNSymbol: AMGN AssetType: Common Stock Name: Amgen Inc Description: Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; Adaptive Biotechnologies; and Eli Lilly and Company, as well as has a strategic agreement with McKesson Corporation to help improve cancer care in community oncology settings. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Exchange: NASDAQ Currency: USD Country: USA Sector: Healthcare Industry: Drug Manufacturers-General Address: One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 FullTimeEmployees: 23400 FiscalYearEnd: December LatestQuarter: 2020-09-30 MarketCapitalization: 142916681728 EBITDA: 12647000064 PERatio: 19.7992 PEGRatio: 1.5407 BookValue: 18.781 DividendPerShare: 7.04 DividendYield: 0.0287 EPS: 12.399 RevenuePerShareTTM: 42.405 ProfitMargin: 0.2942 OperatingMarginTTM: 0.3757 ReturnOnAssetsTTM: 0.0945 ReturnOnEquityTTM: 0.6718 RevenueTTM: 24987000832 GrossProfitTTM: 19006000000 DilutedEPSTTM: 12.399 QuarterlyEarningsGrowthYOY: 0.049 QuarterlyRevenueGrowthYOY: 0.12 AnalystTargetPrice: 255.28 TrailingPE: 19.7992 ForwardPE: 13.7741 PriceToSalesRatioTTM: 5.5562 PriceToBookRatio: 12.4317 EVToRevenue: 6.4341 EVToEBITDA: 12.4492 Beta: 0.7616 52WeekHigh: 261.431 52WeekLow: 173.5108 50DayMovingAverage: 229.69 200DayMovingAverage: 238.9139 SharesOutstanding: 582169024 SharesFloat: 581126530 SharesShort: 6958047 SharesShortPriorMonth: 6912555 ShortRatio: 2.82 ShortPercentOutstanding: 0.01 ShortPercentFloat: 0.012 PercentInsiders: 0.188 PercentInstitutions: 77.988 ForwardAnnualDividendRate: 7.04 ForwardAnnualDividendYield: 0.0287 PayoutRatio: 0.3993 DividendDate: 2021-03-08 ExDividendDate: 2021-02-11 LastSplitFactor: 2:1 LastSplitDate: 1999-11-22
NLong
by pivotanalytics
AMGN LONG compared with the DOWIn order to enhance your plays when it comes to options(stocks), it will help to compare the stock to its relative index it is in. This was a stock I happened to come across just doing some random backtesting and saw a nice 4hr candle that could potentially cause a reaction for more upside. I forgot about it and came back about 2weeks later and saw my area was triggered. We got a reaction to the upside exactly what I was looking for. The second entry came at a time when the indexs (SPX, US30, NAS100) were selling off, so I was looking for any divergence between the stock and its pair. As you can see, the DOW created a lower low basically running for stops while AMGN was holding structure. This was a very strong confirmation of this trade panning out because whenever the DOW would gain strength, it would push AMGN higher and that is seen through current price. The target price is $250 where lies a gap in the market so I am looking for that to get filled. Divergence in the market is when two correlating assets are doing opposite things. If you can spot a divergence aligned with any other confirmations you may have, the trade will most likely playout nicely
NLong
by DesmondMeyer
$AMGN - NR Picks Nov 22Amgen se dedica a descubrir, desarrollar, fabricar y ofrecer terapias humanas en todo el mundo. Se centra en las áreas de inflamación, oncología / hematología, salud ósea, enfermedades cardiovasculares, nefrología y neurociencia. La compañía tuvo una reacción positiva a inicios de mes cuando presentó una actualización de su fármaco para la psoriasis, durante el mes el precio de la acción fue cayendo hasta estar cerca a los niveles pre-reacción. Este retroceso se ve como una oportunidad para Amgen , recordemos que esta compañía es una de las mas importantes del sector. Creemos que el interés de los inversores durante el mes ha cambiado a compañías que están brindando actualizaciones sobre el desarrollo de la vacuna contra el COVID-19.
NLong
by NewroadTrader